Efficacy of apremilast, an oral phosphodiesterase 4 inhibitor, for palmoplantar psoriasis in patients with moderate to severe plaque psoriasis in phase 2 and phase 3 (ESTEEM) trials

Authors
Category Primary study
JournalJournal of the American Academy of Dermatology
Year 2015
This article has no abstract
Epistemonikos ID: 665efc40cdb32a32e88781d96f4fefdbb3f4394e
First added on: Feb 07, 2025